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ORIG INAL PAPER

Deletion of SA β-Gal+ cells using senolytics improves muscle
regeneration in old mice
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Abstract
Systemic deletion of senescent cells leads to robust improvements in cognitive, cardiovascular, and whole-body metabolism, but their role in tissue reparative processes
is incompletely understood. We hypothesized that senolytic drugs would enhance
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regeneration in aged skeletal muscle. Young (3 months) and old (20 months) male
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Computational Biology, GCBDS,
Boehringer Ingelheim Pharmaceuticals
Inc., Ridgefield, Connecticut, USA
5
Department of Athletic Training and
Clinical Nutrition, College of Health
Sciences, University of Kentucky,
Lexington, Kentucky, USA
6

Regenerative Medicine, Boehringer
Ingelheim Pharmaceuticals Inc., Ridgefield,
Connecticut, USA

Correspondence
Charlotte A. Peterson, College of Health
Sciences, University of Kentucky, 900
S. Limestone, CTW 439, Lexington, KY
40536, USA.
Email: cpete4@uky.edu
Present address
Kevin A. Murach, Department of Health,
Human Performance, and Recreation,
and Cell and Molecular Biology Program,
University of Arkansas, Fayetteville,
Arkansas, USA
Funding information
Glenn Foundation for Medical Research;
National Institute on Aging, Grant/Award
Number: AG049806 and AG063944

C57Bl/6J mice were administered the senolytics dasatinib (5 mg/kg) and quercetin
with 1.2% BaCl2 or PBS 7- or 28 days prior to euthanization. Senescence-associated β-
Galactosidase positive (SA β-Gal+) cell abundance was low in muscle from both young
and old mice and increased similarly 7 days following injury in both age groups, with
no effect of D+Q. Most SA β-Gal+ cells were also CD11b+ in young and old mice 7- 
and 14 days following injury, suggesting they are infiltrating immune cells. By 14 days,
SA β-Gal+/CD11b+ cells from old mice expressed senescence genes, whereas those
from young mice expressed higher levels of genes characteristic of anti-inflammatory
macrophages. SA β-Gal+ cells remained elevated in old compared to young mice
28 days following injury, which were reduced by D+Q only in the old mice. In D+Q-
treated old mice, muscle regenerated following injury to a greater extent compared
to vehicle-treated old mice, having larger fiber cross-sectional area after 28 days.
Conversely, D+Q blunted regeneration in young mice. In vitro experiments suggested
D+Q directly improve myogenic progenitor cell proliferation. Enhanced physical function and improved muscle regeneration demonstrate that senolytics have beneficial
effects only in old mice.
KEYWORDS

regeneration, satellite cells, senescence, senolytics, skeletal muscle
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2020; Li et al., 2021; Palmer et al., 2019; Zhang, Swarts, et al., 2019;
Zhu et al., 2015), all while improving physical function and extending

One hallmark indicator of organismal aging is the accumulation of se-

lifespan (Xu et al., 2018). Although there are conflicting reports on

nescent cells; cells that have permanently exited the cell cycle due to

the abundance of senescent cells in resting muscle from old mice

factors such as replicative exhaustion, unrepaired DNA damage, or

(Dungan et al., 2020; Silva et al., 2019), recent studies have demon-

oncogene stress (reviewed in Gorgoulis et al. (Gorgoulis et al., 2019)).

strated that 10 days following cardiotoxin injury to muscle, seno-

The accumulation of these cells has been linked to altered metabo-

lytic drugs elevate satellite cell numbers and are associated with a

lism (Ademowo et al., 2017; Palmer et al., 2019), reduced cognitive

greater number of large myofibers (Doan et al., 2020), in addition to

function (Ogrodnik et al., 2019; Zhang, Swarts, et al., 2019), lower

reducing the number of SA β-Gal+ cells in damaged muscle tissue

physical function (Baker et al., 2016; Xu et al., 2018), and shortened

(Chiche et al., 2017). The goals of this study were to determine (1)

lifespan (Baker et al., 2016; Xu et al., 2018) largely through the pro-

the origin of senescent cells in injured muscle, (2) if injury causes a

duction of the senescence-associated secretory phenotype (SASP).

sustained elevation in senescent cells in muscle from aged mice, and

The SASP is comprised of a diverse panel of chemokines, inflam-

(3) if removing senescent cells using senolytics (dasatinib and quer-

matory cytokines, proteases, growth factors, and hundreds of other

cetin) enhances muscle regeneration in old mice over a time course

molecules (Basisty et al., 2020; Coppe et al., 2010) that negatively

of 28 days.

affect the surrounding environment, causing inflammation and induction of senescence in neighboring cells. Genetic (Baker et al.,
2011, 2016; Palmer et al., 2019) and pharmacologic (Ogrodnik et al.,
2019; Xu et al., 2018; Zhang, Swarts, et al., 2019) clearance of senescent cells throughout the body improves all of the aforementioned

2
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2.1 | Animals

outcomes, reducing the burden of the SASP on whole-body metabolic and physiologic homeostasis.

Young (3 months; n = 44) and old (20 months; n = 38) male C57Bl/6J

Although senescent cell accumulation is generally considered

mice were obtained from Jackson Labs (Bar Harbor, ME). All ani-

maladaptive, senescent cells are essential to the reparative pro-

mal procedures were approved by the IACUC of the University

cess in regenerating tissues and wound healing (Da Silva-A lvarez

of Kentucky. Mice were housed in a temperature and humidity-

et al., 2020; Demaria et al., 2014; Sarig et al., 2019). Skeletal mus-

controlled room, maintained on a 14:10-h light-dark cycle, and food

cle is especially adept at repair, as muscle is completely regener-

and water were provided ad libitum. Mice were euthanized via exsan-

ated 28 days following barium chloride (BaCl2) injury in the mouse

guination under isoflurane anesthesia, followed by cervical disloca-

(Hardy et al., 2016). With aging, regeneration is impaired, result-

tion, and were fasted 6 h prior to euthanization. The study originally

ing in smaller muscles and muscle fibers when compared to young

included n = 40 old mice, but two old mice died before the end of

mice following BaCl2 injury (Blanc et al., 2020; Endo et al., 2020;

the study. During tissue removal, the TA was weighed and then cut

Lee et al., 2013). There are various contributing factors to com-

lengthwise; ~1/3 of the muscle was snap frozen in LN2 and stored

promised regeneration with age including fewer muscle stem cells

at −80°C for RNA isolation and ~2/3 of the muscle was covered in

(satellite cells) (Dungan et al., 2020; Shefer et al., 2006, 2010), re-

OCT, frozen in LN2-cooled isopentane, and stored at −80°C for im-

duced satellite cell function (Pietrangelo et al., 2009), and altered

munohistochemistry (IHC).

muscle environment with higher expression of anti-regenerative
factors such as GDF11 (Egerman et al., 2015); however, the accumulation of senescent cells, identified as senescence-associated

2.2 | Senolytics

β-G alactosidase positive (SA β-G al+), could also play a role. In
young adult animals, SA β-G al+ senescent cells accumulate early

Mice were administered a senolytic cocktail containing 5 mg/kg da-

following damage in muscle (Cazin et al., 2017; Chiche et al., 2017;

satinib (D-3307, LC Labs) and 50 mg/kg quercetin (Q4951, Sigma-

Doan et al., 2020; He et al., 2019; Sarig et al., 2019), but are re-

Aldrich) as described by Xu et al. (Xu et al., 2018). Briefly, 7.5 mg

duced as the tissue regenerates (He et al., 2019; Sarig et al., 2019).

of dasatinib and 75 mg of quercetin were dissolved in 5 ml of 10%

Therefore, this work was designed to test the hypothesis that ab-

polyethylene glycol 400 (PEG 400; 202398, Sigma-Aldrich). We

errant accumulation of senescent cells may negatively impact mus-

chose this volume of PEG 400 because it allowed us to gavage a 30–

cle regeneration during aging.

45 gram mouse with 100–150 μl of D+Q, which is less than the ap-

Senescent cell killing compounds, termed senolytics, are a new

proximate stomach volume of 400 μl in adult mice (McConnell et al.,

category of pharmaceuticals aimed at combating age-associated dis-

2008). Mice were gavaged bi-weekly for 4 months (Figure 1a) with

eases, systemically clearing senescent cells by removing the brakes

D+Q (n = 20 young and n = 19 old) or vehicle (n = 20 young and

on senescent cell anti-apoptotic pathways (SCAPs) (Zhu et al., 2015,

n = 19 old; 10% PEG 400) using 20-gauge disposable polypropylene

2016). The combination of dasatinib and quercetin is especially ef-

feeding tubes (FTP-20-30, Instech, Plymouth Meeting, PA). These

fective at removing senescent cells in a host of tissues (Chu et al.,

mice were then divided into 3 groups of n = 6–7/group.

|
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(a)

(b)
Body Weight (g)

F I G U R E 1 Senolytics lower blood
glucose and improve physical function
in old mice. (a) Study design schematic.
(b) Weekly body weight for YV (white
circles), YS (black and white circles), OV
(blue squares), and OS (black and blue
squares) mice. (c) Fasting blood glucose
measurements in mg/dl. (d) Average
time spent on the rotor rod in seconds.
(e) Average forearm grip strength in
Newtons. (f) Time to cross a 3 cm, 2 cm,
1 cm, and 0.5 cm wide balance beam for
YV (white circles), YS (black and white
circles), OV (blue squares), and OS (black
and blue squares) mice. Error bars indicate
−/+ the standard error of the mean.
*p < 0.05 between young and old for an
individual treatment group (YV vs. OV; YS
vs. OS). ^p < 0.05 between vehicle and
senolytics for a given age group (YV vs.
YS; OV vs. OS). n = 17–20/group
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2.3 | BaCl2 injections

group) and 28 days (n = 5–6/group) post-injection. Subsets of mice
were killed at 7- and 14 days for isolation of SA β-Gal+ cells (n = 8

The left tibialis anterior (TA) muscle was injected with 1.2% BaCl2

young and n = 8 old). Groups of mice (n = 6/group) served as non-

(342920, Sigma-Aldrich) in 5 locations with 10 μl of 1.2% BaCl2 in-

injected controls. Originally, the 28-day BaCl2 groups of mice in-

jected at each location (50 μl total volume). The right TA served as the

cluded n = 7–8/group; however, 2 mice were excluded from each

internal control muscle and was injected with phosphate-buffered

group due to inadequate administration of BaCl2, as determined by a

saline (PBS) in the same manner. Mice were euthanized 7- (n = 6–7/

lack of central myonuclei throughout the muscle.
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forearm grip strength. Three consecutive trials were performed, and
data are shown as the average of the 3 trials.

Mice were fasted 6 h prior to euthanization. Mice were anesthetized under 3% isoflurane, and a small nick was made at the distal
end of the tail. One drop of blood was placed on a blood glucose
test strip and measured with a glucometer (Clarity BG1000, Clarity
Diagnostics). If the blood glucose value was below 100 mg/dl or

2.6 | 5-Dodecanoylaminofluorescein Di-β-D-
galactopyranoside (C12FDG), CD11b labeling, and
fluorescence-activated cell sorting (FACS)

above 250 mg/dl, it was remeasured.
TA muscles from 8 untreated young (4 months) and 8 untreated old

2.5 | Physical function tests

(24 months) mice were injected with 1.2% BaCl2 7- (n = 4/age group)
or 14-  (n = 4/age group) days prior to euthanization as described
above. These muscles were then pooled for this experiment. For

Physical function tests were performed using established protocols

FACS, muscles were processed according to a protocol adapted from

through the University of Kentucky Rodent Behavior Core. To test

the Rando laboratory (Liu et al., 2015) that has previously been used

balance and coordination, rotor rod and balance beam tests were

by our laboratory (Murach et al., 2020). In brief, minced muscle was

performed. Physical function was assessed using a grip strength

digested with collagenase in sorting media (10% normal horse serum/

test. The rotor rod test was performed using a 4-lane SDI ROTOR

Hams F-10/penicillin-streptomycin), then collagenase and dispase in

ROD System (San Diego Instruments) with a 45.7 cm fall height.

sorting media at 37°C. Cells were aspirated with a 20-gauge needle,

Rotor rod data were collected using ROTOR ROD software (San

strained through 40 µm filters, pelleted, and re-suspended in 500 µl

Diego Instruments). The balance beam test was performed using a

of sorting media. To identify senescent cells, we used the ImaGene

homemade device with a fall height of 15 cm and beam widths of

Green fluorescent labeling kit (I2904, Invitrogen), which contains

3 cm, 2 cm, 1 cm, and 0.5 cm. Grip strength was performed using

the β-galactosidase substrate, C12FDG, in a manner consistent with

Columbus Instruments Grip Strength Meter (Columbus Instruments).

others (Cai et al., 2020; Debacq-Chainiaux et al., 2009). Cells were

For all tests, lighting was set at approximately 75 lux and air temper-

incubated with 5 µl chloroquine for 30 min at 37°C to reduce the

ature was maintained at approximately 25°C.

labeling of endogenous β-galactosidase in healthy cells with C12FDG,
then the cell pellet was spun and washed. Cells were re-suspended

2.5.1 | Rotor rod

in 1 ml of sorting buffer and incubated with 1.75 µl of C12FDG and
5 µl of CD11b PE-conjugated primary antibody (101207, BioLegend)
for 1 h at 37°C, then the cell pellet was washed again. Finally, the

Mice were acclimated to the rotor rod for 60 s at 4 rpm. If a mouse

cells were re-suspended in 1 ml of sorting buffer and treated with

fell off during that 1-min acclimation period, they were immediately

20 µl of PETG and propidium iodide. Since chloroquine inhibits en-

placed back on. Thirty minutes after the training session, mice were

dogenous but not SA β-Gal (Poot & Arttamangkul, 1997; Tietz et al.,

placed on the rotor rod with a ramp-up profile set at 0–4 0 rpm and

1990), aliquots of SA β-Gal negative cells that were treated with and

0–300 s. No mice were able to stay on the rotor rod for 300 s. Mice

without chloroquine were used to determine gating (Figures S2a,b).

performed 3 consecutive trials, and data are shown as the average

Cells were sorted using an iCyt FACS machine (Sony Biotechnology).

value among the 3 trials.

Following FACS, cells were pelleted at 500 RPM onto slides using
a Cytospin™ 4 (Thermo Scientific), or prepared for RNA isolation.
Slides were then dried for 15 min and incubated in DAPI (1:10,000;

2.5.2 | Balance beam

D1306, Invitrogen), cover slipped in PBS and glycerol (1:1) and imaged to visualize C12FDG+ and CD11b+ cells. Cells were also stained

Mice were acclimated by allowing them to traverse back and forth

for senescence-associated β-Galactosidase (SA β-Gal).

on the 3 cm balance beam for 60 s. After a 30-min rest, mice were
given up to 60 s to cross each beam. Mice started on a 3 cm wide
beam and progressively moved to a 2 cm, 1 cm, and 0.5 cm beam.
The time to cross and number of foot slips were recorded.

2.7 | Myogenic progenitor cell (MPC) treatment
with senolytics and in vitro proliferation assay
Myogenic progenitor cells from young (4 months) and aged

2.5.3 | Grip strength

(24 months) mice were used for experimentation. On ECM-coated 6-
well plates, 20 × 103 MPCs from young and aged mice were treated

Forearm grip strength was assessed over 3 consecutive trials. Mice

with 250 nM dasatinib and 50 µm quercetin in growth media for

were gently picked up by their tail and held in front of the grip

24 h; cells without senolytics served as controls. After 24 h, cells

strength meter. Once the mouse grabbed the grip strength meter,

were washed and treated with 5 µm EdU (E10187, Invitrogen) in

they were quickly, but gently, pulled backwards to measure the

growth media for another 24 h to quantify DNA synthesis. After

|
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24 h, growth media was removed, and cells were washed in PBS and

sections were incubated in TSA AF594 (1:500; B40957, Invitrogen)

fixed in 4% paraformaldehyde (PFA) for 10 min. EdU was detected

diluted in DAPI staining solution (1:10,000; D1306, Invitrogen) for

using Click It chemistry adapted from Kirby et al. (Kirby et al., 2016),

15 min, washed in PBS, and cover slipped in PBS and glycerol (1:1).

followed by counterstaining with DAPI.

2.8 | Immunohistochemistry (IHC)

2.9 | Senescence-associated beta-galactosidase
(SA β-Gal)

All IHC was performed on fresh frozen muscle cross-sections.

Senescence-associated beta-galactosidase was adapted from a pre-

Muscle tissue was removed from −80°C storage and placed into a

viously published protocol by our laboratory (Dungan et al., 2020).

cryostat (HM525 NX; Thermo Fisher) set at −24°C. After the tissue

Briefly, slides containing muscle sections and cells were fixed in 0.5%

warmed to −24°C, 8 μm sections were cut and allowed to dry for

glutaraldehyde for 5 min at room temperature and washed in PBS.

at least 1 h before IHC analysis or slides were stored at −80°C for

After washing, sections were incubated in freshly made staining so-

future experiments. For all IHC experiments, no primary antibody

lution that contained: 1 mg/ml X-gal in DMF, 5 mM potassium fer-

controls were used to determine background signal. Data from PBS-

rocyanide, 5 mM potassium ferricyanide, 5 M sodium chloride, 1 M

injected TAs (7 and 28 days) were merged into one group.

magnesium chloride, and 0.2 M citric acid/Na phosphate buffer pH
6.0 ± 0.05. Muscle sections were incubated in staining solution for
72 h at 37°C in a dark hybridization oven, with fresh solution added

2.8.1 | Embryonic myosin heavy chain (eMyHC)/
Laminin/DAPI

every 24 h. Afterward, sections were washed in PBS for up to 24 h
to remove salt crystals (this does not affect staining). Sections were
then post-fixed in 0.5% glutaraldehyde for 10 min, washed in PBS,

Sections were blocked in 2% bovine serum albumin (BSA) plus

briefly stained (1 min in each) for hematoxylin and eosin to identify

M.o.M. (MKB-2213, Vector Labs) for 60 min. Sections were then

fibers and label nuclei, cleared, and then cover slipped using Cytoseal

incubated in primary antibodies against eMyHC (supernatant 1:20;

60 (8310-16, Thermo Scientific) permanent mounting medium.

F1.652, Developmental Studies Hybridoma Bank) and laminin
(1:200; L9393, Sigma-A ldrich) diluted in 2% BSA for 90 min,
washed in PBS, and incubated in secondary antibodies against

2.10 | Automated muscle fiber analysis

Ms IgG1 AF594 (1:200; A-21125, Invitrogen) and Rb IgG AF488
(1:200; A-11008, Invitrogen) diluted in PBS for 60 min. Sections

Average myofiber cross-sectional area (CSA) quantification was per-

were washed, incubated in DAPI (1:10,000; D1306, Invitrogen) for

formed using MyoVision (Wen et al., 2018). eMyHC and laminin la-

15 min, washed in PBS, and cover slipped using PBS and glycerol

beled images were used to automatically determine CSA of eMyHC+

(1:1).

and eMyHC-  fibers by MyoVision, with CSAs below 100 µm2 and

above 6000 µm2 excluded from the analysis. On average, greater
than 1000 fibers were analyzed for each muscle to quantify my-

2.8.2 | Pax7/Laminin/DAPI

ofiber CSA. For all images, parts of the cross-section that appeared

Sections were fixed in 4% PFA for 10 min, washed in PBS, incubated

that were not damaged by BaCl2, as determined by a lack of eMyHC

to be folded or damaged during cryosectioning, along with regions
in 3% H2O2 for 10 min, and washed again in PBS. Heat-mediated

expression at 7 days or central nuclei at 7 and 14 days (example in

antigen retrieval was performed in 10 mM sodium citrate pH 6.5.

Figure S1a), were manually excluded from the analysis.

Sections were placed in 65°C 10 mM sodium citrate and then gradually heated to 92°C (~20 min) using a water bath. Once at 92°C, sections remained in the 10 mM sodium citrate for 12 min, then allowed

2.11 | RNA isolation

to cool for 60 min. Sections were then washed in PBS, blocked in
2% BSA plus M.o.M. (Vector Labs) for 60 min, washed in PBS again,

Frozen muscle and freshly isolated cells were placed into 1.5 ml

and incubated in primary antibodies against Pax7 (concentrate

Safe-L ock Eppendorf tubes (022363212, Eppendorf) containing

1:100; PAX7, Developmental Studies Hybridoma Bank) and laminin

QIAzol Lysis Reagent (79306, Qiagen) and homogenized using

(1:200; L9393, Sigma-Aldrich) diluted in 2% BSA overnight. The fol-

2.0 mm zirconium oxide beads (ZROB20, Next Advance) in a Bullet

lowing day, sections were washed in PBS, incubated in a second-

Blender bead homogenizer (BBY24M, Next Advance) at max speed

ary antibody against Ms IgG1 Biotin (1:1000; 115-065-205; Jackson

until the muscle was completely disintegrated (3–4, 1-min cycles).

ImmunoResearch) in 2% BSA for 90 min, washed in PBS, and incu-

RNA was isolated using the RNeasy Plus Mini Prep kit (74136,

bated in secondary antibodies streptavidin horseradish peroxidase

Qiagen); however, we utilized the Qiagen guanidine/phenol-b ased

(1:500; S-911, Invitrogen) and Rb IgG AF488 (1:200; A-11008,

protocol instead of the protocol associated with this kit. RNA

Invitrogen) diluted in PBS for 75 min. Following another PBS wash,

concentration was determined via NanoDrop (NanoDrop 2000,

6 of 17
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SA β-Gal/Hematoxylin/Eosin

Thermo Fisher), and RNA integrity numbers (RINs) were quanti-

(a)

fied using a 2100 Bioanalyzer (Agilent). All RINs were >8.0 with an
average value of 9.1.

2.12 | Statistical analysis
For analyses comparing four groups (young vehicle, young senolytic,
old vehicle, old senolytic) at any given time point (PBS-injected, 7D-
post-BaCl2, 28D-post-BaCl2), a two-way ANOVA was performed
Holm-Sidak post hoc test was used to identify significant comparisons between age (young vs. old) and treatment (vehicle vs. senolytic) groups. A repeated measures two-way ANOVA was used to
determine significance for body weight each week over the course
of the study. Statistics were performed using Prism 9 software for
Mac (GraphPad Software).

3

|

R E S U LT S

3.1 | D+Q-treated old mice have improved physical
function
Young and old C57Bl/6J mice were treated with a senolytic
cocktail of D+Q bi-weekly for 4 months (Figure 1a), so the mice
were 7 months and 24 months of age, respectively, at the time
of functional testing and tissue collection for immunohistochemical analyses. This treatment regimen has previously been shown
to improve physical function in old mice (Xu et al., 2018). There
was no effect of senolytics on body mass (Figure 1b); however,
lower fasting blood glucose was observed in old senolytic-t reated
(OS) mice compared to old vehicle-t reated mice (OV, Figure 1c).
Physical function assessments showed improvements in rotor rod
(Figure 1d) and balance beam (Figure 1f) in OS mice, whereas grip
strength was unchanged and remained significantly lower than

(b)
SA β-Gal+ Cells/106 µm2

with significance set at p < 0.05. If significance was detected, a

80
70
60
50
40
30
12

PBS

7D BaCl

28D BaCl

*

10
8
6
4
2

^

p=0.10

0

YV YS

OV OS

YV YS

OV OS

YV YS

OV OS

F I G U R E 2 Senolytics lower SA β-Gal+ cell burden 28 days
following BaCl2 injury. (a) Representative image of SA β-Gal (blue
staining outlined in black), hematoxylin (dark purple nuclei), and
eosin (light purple cytoplasm). (b) SA β-Gal+ cell abundance per
area in YV, YS, OV, and OS mice. Young mice are labeled with white
bars and old mice are labeled with blue bars. Error bars indicate −/+
the standard error of the mean. *p < 0.05 between young and old
for an individual treatment group (YV vs. OV; YS vs. OS). ^p < 0.05
between vehicle and senolytics for a given age group (YV vs. YS;
OV vs. OS). n = 12–14/group for PBS-injected mice. n = 5–6/group
for 7- and 28-day BaCl2-injected mice

3.3 | D+Q preferentially reduces senescence-
associated β-Galactosidase (SA β-Gal+) cell burden in
old mice 28 days following injury

young mice (Figure 1e). For all outcomes in Figure 1, there was
no significant difference between young vehicle-t reated (YV) and

To test the effect of D+Q on muscle regeneration, the tibialis ante-

young senolytic-t reated (YS) groups.

rior (TA) muscles of YV, YS, OV, and OS mice were injected with either PBS or BaCl2 and harvested after 7- or 28 days (Figure 1a). Using

3.2 | D+Q does not have a substantial effect on
systemic inflammation markers in serum

SA β-Gal staining (representative images, Figure 2a and Figure S1b),
we found that SA β-Gal+ cells were of very low abundance in PBS-
injected muscle regardless of age (Figure 2b); although there was a
trend (p = 0.10) to have more senescent cells in PBS-injected old TA

We utilized a multiplex ELISA for 36 inflammatory markers, including

muscles (Figure 2b). This could be due to the physical trauma from the

common SASP markers such as IL-1α, IL-1β, IL-6, and MCP-1, to de-

needle injection, as SA β-Gal+ cells were not detected in injection-

termine if D+Q reduce markers of systemic inflammation. Of the 36

naïve muscle in either age group (data not shown). Following BaCl2

proteins in the ELISA, only 14 were sufficiently abundant in serum

injection, SA β-Gal+ cells were present throughout the damaged

for analysis. Of the 14 proteins, only MCP-3 abundance was affected

muscle area, identified by embryonic myosin heavy chain-expressing

by D+Q; it was lower in YS mice compared to YV with no effect in

(eMyHC+) fibers (Figure S1a), with small areas spared from damage

the old mice (Table S1). Thus, there does not appear to be a large
effect of D+Q on the markers of systemic inflammation included on
the panel.

largely free of SA β-Gal+ cells (Figure S1b). There was a large in-

crease in SA β-Gal+ cells at 7 days (~0.2 per 106 μm2 in PBS-injected
compared to ~50 per 106 μm2 in BaCl2 injected), with no difference
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in the abundance of SA β-Gal+ cells between age groups at this time

showed that C12FDG− cells (Figure 3a) were also CD11b− (Figure 3c).

point. At 28 days post-injury, OV mice had significantly more SA β-

Greater than 90% of the C12FDG+ cells (Figure 3b) were CD11b+

Gal+ cells than YV mice (Figure 2b). There was no effect of D+Q

(Figure 3d). The white circles in Figure 3b,d indicate the less than

7 days following injury in young or old mice (Figure 2b); however,

10% of C12FDG+ cells are CD11b-. Staining for SA β-Gal of sorted

there were significantly fewer SA β-Gal+ cells in OS mice 28 days

cells confirmed that the GFP+ cells were SA β-Gal+ positive (Figures

after injury compared to OV (Figure 2b).

S2f,g).
To determine if the phenotype of the CD11b+ cells differed

3.4 | SA β-Gal+ cells that emerge during muscle
regeneration are primarily immune cells

in young and old mice following injury, FACS-isolated cells from
young and old mice (n = 4 in each age group) were pooled and
profiled using low-input RNA sequencing (RNA-s eq) due to the
relatively low amount of RNA contained within cells. We were un-

Macrophage infiltration is necessary for muscle repair (Liu et al.,

able to isolate sufficient cells at the 28-day time point so RNA

2017; Segawa et al., 2008; Wang et al., 2014) and reports show

was isolated from cells at 7-  and 14 days post-injury. Comparing

that macrophages can express SA β-Gal (Childs et al., 2016): mac-

C12FDG+/CD11b+ from muscle of young and old mice, there were

rophages polarizing from M1 to M2 display high expression of se-

relatively few differentially expressed genes 7 days post-B aCl2

nescence markers p16 and SA β-Gal, which are then reduced in fully

injury (DEGs; 52 genes); however, some of the more highly ex-

differentiated M2 macrophages (Hall et al., 2016, 2017). Therefore,

pressed DEGs in cells from old compared to young mice included

we hypothesized that the large number of SA β-Gal+ cells 7 days

chemokines Ccl8, Ccl12, Cxcl9, and Cxcl10, as well as Neat1, an acti-

following BaCl2 were likely infiltrating macrophages in muscle from

vator of the macrophage inflammasome (Zhang, Cao, et al., 2019),

both young and old mice. We further hypothesized that these cells

and Klf4, a transcription factor that upregulates the senescence

are normally cleared following muscle repair, or complete transition

marker and cell cycle inhibitory protein, p21 (Gamper et al., 2012;

to an M2-like phenotype in young muscle, whereas in old muscle,

Xu et al., 2016) (File S1). At 14 days, there were fewer C12FDG+/

the macrophages become senescent over time. We used C12FDG to

CD11b+ cells in regenerating muscle from young (9.9% of total cell

label SA β-Gal+ cells fluorescently green, in the presence of chlo-

count) compared to old mice (11.8% of total cell count), suggestive

roquine, which raises lysosomal pH of the cell to limit the labeling

of clearance from the muscle by this time point preferentially in

of non-senescent cells by reducing endogenous, but not SA β-Gal

muscle from young mice, and there were hundreds of DEGs be-

enzyme activity, as shown by fluorescence-activated cell sorting

tween cells from young and old mice. In the C12FDG+/CD11b+

(FACS) (Figures S2a,b) (Cahu & Sola, 2013; Nogueira-Recalde et al.,

cells that were present in old mice at 14 days, there was significant

2019; Poot & Arttamangkul, 1997; Tietz et al., 1990). Cells were

upregulation of genes encoding chemokines and inflammatory cy-

also labeled using an antibody against the pan macrophage marker,

tokines (741 genes), including well-a ccepted components of the

CD11b, and GFP+ and GFP− cells were isolated by FACS at 7- and

SASP (i.e., Ccl2, Il-1a, Il-1b, Tnf, and Gdf15), in addition to higher ex-

14 days post-BaCl2 injury (Figures S2c–e). Immunocytochemistry

pression of Cdkn1a, encoding p21 (File S1). In C12FDG+/CD11b+

C12FDG(a)

(b)

(c)

(d)

C12FDG/DAPI
CD11b/DAPI

F I G U R E 3 Most C12FDG+ cells are
CD11b+ suggesting they are infiltrating
macrophages. Muscles from old mice
14 days following injury were dissociated
and cells sorted as described in Figure
S2. Representative images of isolated (a)
C12FDG− and (b) C12FDG+ cells. Cells
were immunoreacted with a CD11b
antibody (red) shown in (c) C12FDG−/
CD11b+, and (d) C12FDG+/CD11b+
cells. White circles in b and d indicate
rare C12FDG+/CD11b− cells. Cells were
also labeled with DAPI (blue) to visualize
nuclei. n = 1 pooled sample of 4 TAs for
each group. Scale bar equals 100 μm

C12FDG+
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cells from young mice, there were few inflammatory cytokines ex-

Because senescent cells have been associated with tissue fibro-

pressed at 14 days. On the other hand, expression of Adamts1 and

sis in the lung (Citrin et al., 2013; Minagawa et al., 2011; Schafer

Pdgfb was higher in cells from young compared to old mice, factors

et al., 2017), total fibrous collagen content, as well as the content

secreted by M2 macrophages shown to promote muscle stem cell

of loosely and tightly packed collagen, were assessed using Sirius

activation (Doumit et al., 1993; Du et al., 2017) (File S1). Together,

red staining followed by visible light (Figure S4a) and polarized light

our data suggest that SA β-G al+ cells are CD11b+ macrophages at

(Figure S4c) imaging, respectively, quantified in Figure S4b,d. Overall

7 days post-injury in both young and old mice, whereas by 14 days

collagen abundance was unchanged by D+Q, along with no effect of

these cells from old mice display a SASP and upregulation of p21,

age (Figure S4b). Collagen organization was assessed in a manner

indicating they are becoming senescent.

consistent with Smith et al. (Smith & Barton, 2014), and we observed
no difference in the relative organization of collagen (Figure S4d)

3.5 | Muscle regeneration is enhanced in D+Q-
treated old but not young mice
To determine if clearance of senescent cells influenced TA muscle re-

between any group 28 days following BaCl2 injury.

3.6 | Satellite cell abundance and activation is
higher with D+Q in old mice

generation, muscles of YV, YS, OV, and OS mice injected with either
PBS or BaCl2 were harvested for IHC after 7- or 28 days. Normalized

Satellite cells are essential for muscle regeneration (Fry et al., 2015;

TA mass was reduced 7 days post-injury but was not significantly

Relaix & Zammit, 2012) and are lower with aging (Dungan et al.,

different between YV and OV mice (Figure 4a). Fiber CSA was nearly

2020; Shefer et al., 2006, 2010), so we asked whether changes in

50% lower at 7 days, with OV mice having a smaller mean fiber CSA

satellite cell abundance potentially contributed to enhanced mus-

compared to YV (Figure 4b). The greater reduction in fiber CSA

cle regeneration in D+Q-treated old mice. Satellite cell abundance

compared to muscle mass 7 days post-injury is likely due to edema

per area was lower in OV compared to YV PBS-injected mice, and

and infiltrating immune cells. Muscle regeneration was clearly ongo-

in OV compared to YV mice 7 days following BaCl2-injected muscle

ing as eMyHC-expressing fibers were apparent in both age groups

(Figure 5a,b,d), with no difference between YV and OV at the 28-

(representative images shown in Figure 4c–f ). At the 28-day time-

day time point (Figure 5c,d). There was no effect of D+Q on satellite

point, YV mice had larger muscles than OV (Figure 4a), in addition to

cell abundance in PBS-injected young mice, whereas D+Q treatment

having larger fiber CSA (Figure 4b). Although fiber CSA was similar

in old PBS-injected mice resulted in higher satellite cell abundance

between uninjured and injured muscle in young mice after 28 days,

(Figure 5d). At 7 days following injury, there was a trend for satellite

BaCl2-injected muscles from YV mice were larger than PBS-injected

cells to be elevated in OS mice when compared to OV mice (Figure 5d,

muscles. This is likely due to an increase in total fiber number follow-

p = 0.09). There were no differences between groups after 28 days

ing BaCl2 injection (Figure S3a–c). Fibers in OV mice were smaller

(Figure 5d). To determine if the difference in satellite cell abundance

28 days following BaCl2 injection compared to OV following PBS in-

early during regeneration could be due to the effect of D+Q directly

jection (Figure 4b); however, muscle mass was not different between

on satellite cells, we isolated myogenic progenitor cells (MPCs) from

those groups (Figure 4a). Similar to the young, this can be attributed

young (4 month) and old (24 month) mice and performed a 24-h pro-

to a difference in total fiber number, as OV 28-day BaCl2-injected

liferation assay with and without a 24-h pre-treatment with D+Q

mice had more fibers than OV PBS injected (Figure S3c).

using an EdU incorporation assay to assess newly synthesized DNA.

D+Q had different effects on muscle regeneration in young com-

There was no significant effect of D+Q on MPC proliferation in cells

pared to old mice. In young mice, fiber CSA of YS mice was smaller

isolated from young mice (Figure 5e,g,i), whereas proliferation of

when compared to YV at both 7- and 28 days post-injury (Figure 4b),

MPCs from old mice was augmented (Figure 5f,h,i). Thus, we con-

which corresponded to a leftward shift in the histogram of fiber size

clude that some of the beneficial effect of D+Q on regeneration in

distribution in YS and lower abundance of larger fibers compared to

old mice is due to improved satellite cell proliferation.

YV at 28 days (Figure 4g). At 7 days post-injury, YV had fewer small
regenerating fibers, which corresponded with fewer small eMyHC+
fibers than YS (Figure S3d,e). There was no effect of D+Q on mean
fiber CSA (Figure 4b) or mean fiber size distribution in old mice

3.7 | Effects of D+Q on gene expression in old
mice 7 days following injury

7 days following injection (Figure S3f), but a tertiary analysis of fiber
size distribution of nascent eMyHC+ fibers revealed that OS mice

We performed RNA-seq on whole muscle to identify pathways that

had a great proportion of larger regenerating fibers than OV (Figure

were affected by D+Q administration during muscle regeneration

S3g). After 28 days, fiber CSA in OS mice was significantly larger

in old mice. We focused on the 7-day time point because of our ob-

than OV mice (Figure 4b), corresponding to a rightward shift to a

servation of higher expression of select chemokines in macrophages

larger fiber size distribution in OS compared to OV mice (Figure 4h).

from old mice relative to young beginning at 7 days post-injury,

Thus, D+Q appear to augment muscle regeneration in old mice and

and the difference in satellite cells at that time point. In OV vs. OS

impair regeneration in young mice.

muscle tissue, there were 4,474 DEGs with an adjusted p-value of
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F I G U R E 4 Differential effects of senolytics on muscle fiber size during regeneration in young and old mice. Young mice are labeled
with white bars and old mice are labeled with blue bars. (a) TA weight normalized to body weight. (b) Mean fiber CSA. (c–f ) Representative
images of immunohistochemical staining for eMyHC (red), laminin (green), and DAPI (blue) in PBS-injected, (c’–f ’) 7 days following BaCl2
injection, and (c’’–f ’’) 28 days following BaCl2 injection. (g) Fiber size distribution for YV and YS groups. (h) Fiber size distribution for OV and
OS groups. Error bars indicate −/+ the standard error of the mean. *p < 0.05 between young and old for an individual treatment group (YV
vs. OV; YS vs. OS). ^p < 0.05 between vehicle and senolytics for a given age group (YV vs. YS; OV vs. OS). n = 12–14/group for PBS-injected
mice. n = 5–6/group for 7- and 28-day BaCl2-injected mice. Scale bar equals 50 μm
<0.05; 2,115 DEGs met our criteria for analysis (see Appendix S1;

in OS and higher expression of SASP genes in OV. These differences

Figure 6a and File S2). Of the 2115 DEGs, 999 were downregulated

included lower Ccl2, Serpine1, and Tlr7 in OS (File S2). There was also

and 1116 were upregulated between OV vs. OS mice (Figure 6b).

reduced expression of anti-apoptotic genes, specifically, Survivin (File

Pathway analysis revealed that the most downregulated pathway in

S2), which inhibits caspase activity to negatively regulate apoptosis

OS relative to OV was inflammatory response (Figure 6c), which cor-

(Shin et al., 2001). Pathway analyses revealed extracellular matrix

responded with lower expression of genes associated with the SASP

(ECM) remodeling and negative regulation of angiogenesis pathways

10 of 17
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were also lower in OS when compared to OV mice (Figure 6c). Genes
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DISCUSSION

associated with the induction or maintenance of senescence, such as
In the present study, we examined the contribution of D+Q to early

ment (File S2). The most upregulated pathways in OS mice included

(7 days) and late (28 days) muscle regeneration in both young and old

pathways specific to energy production and muscle contraction (File

mice. In old mice, D+Q lowered fasting blood glucose, while improv-

S2; Figure 6d). Specifically, metabolic pathways, such as the TCA

ing physical function. Following injury, SA β-Gal+ cells accumulate in

cycle and mitochondrial respiration, were among those that were

muscle from both young and old mice at 7 days and remain elevated

higher in OS mice. In total, D+Q appear to have a beneficial effect

in vehicle-treated old mice 28 days after injury. Vehicle-treated old

on the muscle environment at 7 days post-BaCl2 injury in old mice

mice had a blunted or delayed (Shavlakadze et al., 2010) regenera-

that likely mediates the significant fiber hypertrophy and improved

tive response following BaCl2 injury compared to young mice, which

regeneration observed at 28 days.

was rescued by D+Q. Specifically, in old mice, we observed fewer

Pax7/Laminin/DAPI

Cdkn2a (p16) and Myc (C-Myc), were also lower following D+Q treat-
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F I G U R E 5 Senolytics increase satellite
cell abundance in old mice. Young mice
are labeled with white bars and old mice
are labeled with blue bars. Representative
images of immunohistochemical staining
for Pax7 (pink), laminin (green), and DAPI
(blue) from (a) PBS-injected, (b) 7 days
following BaCl2 injection, and (c) 28 days
following BaCl2 injection. (d) Satellite cell
abundance per area. Error bars indicate
−/+ the standard error of the mean.
Scale bar equals 50 μm. Representative
images of EdU incorporation (red) into
MPCs in vitro. Nuclei are visualized
with DAPI (blue). (e) YV MPCs, (f) OV
MPCs, (g) YS MPCs, and (h) OS MPCs. (i)
Quantification of percent EdU+ MPCs.
*p < 0.05 between young and old for an
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senolytics for a given age group (YV vs.
YS; OV vs. OS). n = 12–14/group for PBS-
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experiments, n = 3 technical replicates per
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of RNA-seq of muscle from vehicle- and senolytic-treated old mice 7 days following injury displayed by (a) Heat map and (b) Volcano plot.
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eMyHC+ fibers and more satellite cells early in the regenerative

the pro-inflammatory state (Hall et al., 2016), only in old muscle.

process, along with larger fibers after 28 days. Interestingly, D+Q

Although the majority (>90%) of SA β-Gal+ cells were also CD11b+

appeared to blunt muscle regeneration in young mice, as young

and likely not senescent 7 days following injury, we cannot discount

D+Q-treated mice have smaller fibers 7- and 28 days after BaCl2 in-

the potential contribution of the remaining ~10% to defective re-

jury. Further, we show that D+Q affect gene expression in inflamma-

generation in old mice, as a small number of senescent cells have

tory and energy producing pathways in old mice, which are essential

been suggested to have a large impact on tissue homeostasis. SA β-

for muscle regeneration. Our results corroborate and expand upon

Gal+ cells may have a key role in the repair of damaged tissue early

recent studies showing that following muscle injury, senolytics can

during regeneration; however, SA β-Gal+ cells remained elevated

effectively lower the senescent cell burden (Chiche et al., 2017), in

in muscle 28 days after injury in old mice, potentially negatively

addition to elevating satellite cell number and causing a shift toward

impacting regeneration. D+Q reduced SA β-Gal+ cells in old mice

larger fibers (Doan et al., 2020) in old mice. Collectively, these data

to that observed in vehicle-treated young mice, which may directly

highlight the potential therapeutic benefits of D+Q following muscle

contribute to enhanced fiber recovery. In young mice, SA β-Gal+/

injury in older individuals and provide a word of caution for adminis-

CD11b+ cells appear to be transitioning to a more M2-like pheno-

tration of D+Q in the young.

type, with higher expression of Adamts1 and Pdgfb, factors secreted

Senescent cells are shown to accumulate in nearly all tissues;
however, senescent cell accumulation in skeletal muscle is extremely
low or even undetectable during normal healthy aging (Dungan

by M2 macrophages which promote satellite cell activation (Doumit
et al., 1993; Du et al., 2017).
Following muscle damage, whether physiologic (i.e., unaccus-

et al., 2020; Jeyapalan et al., 2007; Sousa-V ictor et al., 2014; Wang

tomed exercise, surgery) or catastrophic (i.e., BaCl2, cardiotoxin),

et al., 2009). Removal of senescent cells does improve certain mea-

satellite cells are an essential component of the regenerative

sures of physical function (Cai et al., 2020; Doan et al., 2020; Xu

process for skeletal muscle (Fry et al., 2015; Relaix & Zammit,

et al., 2018), although it does not seem to affect muscle mass (Baker

2012). Older muscle often contains fewer satellite cells (Dungan

et al., 2016). Dasatinib and quercetin are two senolytic compounds

et al., 2020; Shefer et al., 2006, 2010), which is likely a contrib-

that, when combined (Zhu et al., 2015), have been effective at en-

uting factor to blunted muscle repair and regrowth with aging.

hancing renal (Li et al., 2021) and heart (Zhu et al., 2015) function,

We observed significantly more satellite cells in senolytic-treated

clearing senescent cells from damaged liver (Chu et al., 2020), im-

old mice 7 days following BaCl2 injection, but no effect in young

proving physical function (Xu et al., 2018) and extending lifespan

mice. An inflammatory environment blunts satellite cell prolifer-

(Xu et al., 2018). Further, both dasatinib and quercetin modulate

ation (Perandini et al., 2018; Tierney et al., 2014), and our whole-

the expression of apoptotic/anti-apoptotic machinery, such as low-

muscle RNA-seq analysis 7 days post-injury revealed an overall

ering anti-apoptotic proteins Mcl-1 (Veldurthy et al., 2008), Bcl-xL

reduction in inflammatory gene expression in muscle from old mice

(Veldurthy et al., 2008), and Survivin (Kim et al., 2008), and ele-

following treatment with D+Q, which may be more conducive to

vating apoptotic protein p53 (Srivastava et al., 2016). The survivin

satellite cell proliferation. D+Q may also have direct effects on sat-

gene was expressed at lower levels at 7 days post-injury in our old

ellite cells, although we have no evidence that satellite cells are

senolytic-treated mice when compared to old vehicle-treated. Very

senescent in the 24-month-old mice, consistent with the work of

little is known about the contribution of senescent cells to muscle

others in 42-month-old mice (Wang et al., 2009) and old primates

regeneration, although a recent report shows that senescent fibro-

(Jeyapalan et al., 2007). It is possible that satellite cells become se-

adipogenic progenitor cells are required for adequate regeneration

nescent in very old age, as isolated satellite cells from geriatric mice

(Saito et al., 2020). This is consistent with work from the Campisi

(>30 months old) appear to senesce in vitro more readily than cells

laboratory showing that senescent cells are needed for adequate

from 24-month-old mice (Sousa-V ictor et al., 2014). On the other

wound healing (Demaria et al., 2014), leading to the classification

hand, our in vitro experiments suggest that D+Q may directly pro-

of senescent cells being either helper or deleterious (Kirkland &

mote satellite cell proliferation, as MPCs isolated from old mice fol-

Tchkonia, 2020). We observed a large increase in SA β-Gal+ cells

lowing treatment with dasatinib and quercetin showed higher EdU

in both young and old mice 7 days following injury, which are likely

incorporation, whereas cells from young mice were not affected.

infiltrating macrophages based on cell surface expression of CD11b,

This may be due to effects on MPC metabolism. Whole-muscle

a pan macrophage marker. Macrophage infiltration is indispensable

RNA-seq showed higher expression of genes in glycolytic and ox-

for normal muscle regeneration, gradually transitioning from a pro-

idative phosphorylation pathways in muscle from old senolytic-

inflammatory M1 state to a more anti-inflammatory, reparative

treated mice compared to vehicle 7 days post-injury, which could

M2 state (Saclier et al., 2013; Tidball, 2017). This change in state

have a significant impact, as defects in ATP production delays

requires the coordinated effort of various factors, including SA β-

muscle regeneration (Arneson-W issink et al., 2020). Quercetin

Gal and p16, which are elevated during M1 to M2 polarization and

has been shown to upregulate mitochondrial biogenesis in muscle

then are reduced following successful transition to an M2 phenoy-

(Davis et al., 2009; Qiu et al., 2018), which would facilitate energy

type (Hall et al., 2016, 2017). RNA-seq data comparing C12FDG+/

production required for proliferation. Further, quercetin has anti-

CD11b+ cells from young and old mice during regeneration sug-

oxidant properties (Zhang et al., 2011), which are maladaptive for

gest these cells are likely becoming senescent or are “stuck” in

muscle growth in young adult rodents (Makanae et al., 2013) and
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humans (Dutra et al., 2019; Paulsen et al., 2014) due to their inhib-

Improvements in glucose uptake following dasatinib + quercetin

itory effect on mTORC1 activation (Ito et al., 2013; Paulsen et al.,

treatment have been reported during diet-induced obesity, which

2014) but could be beneficial for conditions that exhibit basal hy-

was attributed to a reduction of senescent cells in adipose tissue

peractive mTORC1 activation, such as with aging (Dungan et al.,

(Palmer et al., 2019). As blood glucose is moderated by multiple tis-

2016; Joseph et al., 2019; Tang et al., 2019).

sues (pancreas, liver, skeletal muscle, adipose, etc.) it is likely a con-

Quercetin may also directly reduce inflammatory gene expression observed in senolytic-treated compared to vehicle-treated old

certed effort between tissues that mediates the improvements in
blood glucose we observed in old mice.

mice 7 days post-injury. Treatment of U937 differentiated macro-

Together, our data show that clearance of senescent cells is ben-

phages with quercetin reduced the expression of cytokines, TNF

eficial for muscle regeneration, but only in old mice. Most of the SA

and IL-1β, and chemokine, MCP-1 (Overman et al., 2011), factors that

β-Gal+ cells in muscle from old mice following injury are CD11b+

were higher in SA β-Gal+ macrophages from old mice compared to

macrophages, whereas in young mice, macrophages transition to a

young 14 days following injury. A similar observation was made in

reparative phenotype to facilitate muscle regeneration (Jensen et al.,

Raw 264.7-derived M1 macrophages, where quercetin reduced TNF,

2020). By 14 days post-injury, macrophages in adult muscle express

IL-1β, and MCP-1 expression (Kim and Park, 2016; Li et al., 2018).

factors that facilitate satellite cell function and muscle fiber growth,

Thus, in addition to its antioxidant function and beneficial effects

whereas in old mice they express SASP markers. In addition to re-

on mitochondrial biogenesis, quercetin may reduce whole-muscle

ducing the abundance of senescent cells in muscle, senolytics, par-

inflammation, without a concomitant reduction in SA β-Gal+ cells,

ticularly quercetin, may directly promote satellite cell proliferation to

early in the regenerative process.

facilitate regeneration. Senolytics effectively reduce senescent cell

The underlying mechanisms leading infiltrating SA β-Gal+ mac-

burden, increase satellite cell abundance, reduce inflammatory gene

rophages to become senescent following injury in muscle from old

expression, alter expression of ECM genes, and increase expression

mice are currently unknown, but the aged muscle environment is

of genes in muscle metabolic pathways which may collectively aug-

likely a contributor. The ECM in injured muscle from old mice may

ment muscle fiber regeneration, ultimately leading to increased fiber

influence macrophage phenotype (Sicari et al., 2014). RNA-seq

size and improved physical function. There are still many unknowns

comparing OS vs. OV muscle showed lower expression of a host of

about the relationship among senescent cells, skeletal muscle regen-

ECM genes, including 11 collagen genes, 3 integrin genes, and Fn1

eration, and sarcopenia, requiring further study.

(fibronectin). Changes in the ECM may promote senescence and a
SASP in macrophages in muscle from old mice.
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